BeOne Medicines
ONC
#605
Rank
C$59.74 B
Marketcap
C$528.12
Share price
1.92%
Change (1 day)
13.96%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2026 (TTM): C$8.37

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is C$8.48. In 2025 the company made an earnings per share (EPS) of C$3.87 an increase over its 2024 EPS that were of C-$8.85.

EPS history for BeOne Medicines from 2015 to 2026

Annual EPS

Year EPS Change
2026 (TTM)C$8.37116.01%
2025C$3.87-143.75%
2024C-$8.85
2022C-$27.6628.21%
2021C-$21.58-19.96%
2020C-$26.9620.81%
2019C-$22.3131.52%
2018C-$16.97417.57%
2017C-$3.28-37.16%
2016C-$5.22158.95%
2015C-$2.01

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
C-$0.13-101.51%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
C-$1.35-115.89%๐Ÿ‡บ๐Ÿ‡ธ USA